Strategic Channel Expansion Exploit Sonic Healthcare distribution and upcoming funding to push clinical microbiome testing into hospital labs and large clinics; map out enterprise targets, build a sales play around testing as standard GI/health management tool, and propose integration with LIS/EHR.

Therapeutic Collaboration Opportunity MAP 315 development and GMP supply capability create a pathway to partner with pharma companies and contract research organizations for microbiome-based therapies; offer testing data, biomarker analytics, and scalable material supply for trials.

Global Expansion Prospects Post-acquisition, target Invivo Clinical's client base and expand into UK/EU markets; cross-sell MetaPanel and microbiome testing services, and align regulatory/commercial strategies to suit regional healthcare buyers.

Clinician Upsell Potential Leverage the MetaPanel launch to upsell to healthcare professionals, embed testing insights into patient care pathways, and develop payer-ready value propositions focusing on patient outcomes and cost savings.

Growth Readiness Recent funding signals capacity to scale and deepen partnerships; pursue strategic alliances with diagnostic labs, hospital networks, and biotech firms seeking microbiome insights as part of precision health strategies.